I risultati di TAR-210 mostrano una sopravvivenza libera da recidiva del 90 per cento e una risposta completa del 90 per cento rispettivamente nei pazienti con tumore della vescica non muscolo-invasivo ad alto rischio e a rischio intermedio
May 09, 2024 06:31 ET
|
Janssen Cilag International NV
I risultati aggiornati consolidano il potenziale di TAR-210 per trasformare il trattamento del tumore della vescica non muscolo-invasivo con alterazioni del recettore del fattore di crescita dei...
Outbrain Announces First Quarter 2024 Results
May 09, 2024 06:30 ET
|
Outbrain Inc.
NEW YORK, May 09, 2024 (GLOBE NEWSWIRE) -- Outbrain Inc. (Nasdaq: OB), a leading technology platform that drives business results by engaging people across the Open Internet, announced today...
Aveanna Healthcare Holdings Announces First Quarter 2024 Financial Results and Revised 2024 Outlook
May 09, 2024 06:30 ET
|
Aveanna Healthcare Holdings, Inc
First Quarter Revenue was $490.7 million, a 5.2% increase over the prior year Gross margin increased 1.0% to $145.9 million, compared to Q1 2023 First Quarter Net loss was $11.2 million, compared to...
Arhaus Announces First Quarter 2024 Financial Results
May 09, 2024 06:30 ET
|
Arhaus, Inc.
ARHAUS ANNOUNCES FIRST QUARTER 2024 FINANCIAL RESULTS
Sotherly Hotels Inc. Reports Financial Results for the First Quarter Ended March 31, 2024
May 09, 2024 06:30 ET
|
Sotherly Hotels Inc.
WILLIAMSBURG, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Sotherly Hotels Inc. (NASDAQ: SOHO), (“Sotherly” or the “Company”), a self-managed and self-administered lodging real estate investment trust (a...
GigaCloud Technology Inc Announces First Quarter Ended March 31, 2024 Financial Results
May 09, 2024 06:30 ET
|
GigaCloud Technology
-- Revenue Nearly Doubled and Hit Record High; Further Accelerated GigaCloud Marketplace Across all Metrics -- EL MONTE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- GigaCloud...
Jonathan Berlent Joins Merakris as SVP, Head of Strategy and Operations
May 09, 2024 06:30 ET
|
Merakris Therapeutics
Merakris Therapeutics announced today that Jonathan Berlent has joined the company as Senior Vice President, Head of Strategy and Operations.
X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
May 09, 2024 06:30 ET
|
X4 Pharmaceuticals
$125 million of non-dilutive capital extends projected cash runway into late 2025, excluding expected commercial sales from XOLREMDI™ (mavorixafor) XOLREMDI, the first drug indicated in patients with...
Embecta Corp. Reports Second Quarter Fiscal 2024 Financial Results
May 09, 2024 06:30 ET
|
Embecta Corp.
PARSIPPANY, N.J., May 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three and six...
lowRISC Deploys Real Intent Ascent Lint, Meridian CDC, & Meridian RDC for OpenTitan Project
May 09, 2024 06:30 ET
|
Real Intent
lowRISC is deploying Real Intent Ascent Lint, Meridian CDC, & Meridian RDC for OpenTitan Project